- Home
- VKTX vs INDV Comparison
VKTX vs INDV Comparison
Compare VKTX & INDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VKTX | INDV |
|---|---|---|
| Founded | 2012 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.1B | 3.7B |
| IPO Year | 2014 | 2014 |
Fundamental Metrics
Financial Performance| Metric | VKTX | INDV |
|---|---|---|
| Price | $32.87 | $33.86 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $94.44 | N/A |
| AVG Volume (30 Days) | ★ 2.1M | 1.4M |
| Earning Date | 04-29-2026 | 06-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 8100.00 |
| EPS | N/A | ★ 1.64 |
| Revenue | N/A | ★ $1,239,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $20.21 |
| Revenue Growth | N/A | ★ 4.29 |
| 52 Week Low | $22.96 | $10.91 |
| 52 Week High | $43.15 | $38.00 |
Technical Indicators
Market Signals| Indicator | VKTX | INDV |
|---|---|---|
| Relative Strength Index (RSI) | 45.25 | 59.91 |
| Support Level | $30.64 | $33.15 |
| Resistance Level | $35.85 | $35.75 |
| Average True Range (ATR) | 1.48 | 1.27 |
| MACD | -0.29 | 0.26 |
| Stochastic Oscillator | 21.33 | 68.90 |
Price Performance
Historical ComparisonAbout VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, and VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype-selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.
About INDV Indivior PLC
Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).